ACP-196: A second generation Btk inhibitor demonstrates biologic activity in a canine model of B-cell non-Hodgkin lymphoma

被引：9
|
作者：
Gardner, Heather L. [1 ]
Harrington, Bonnie K. [1 ]
Izumi, Raquel [2 ]
Hamdy, Ahmed [2 ]
Kaptein, Allard [3 ]
Van Lith, Bart [3 ]
London, Cheryl A. [1 ]
Byrd, John C. [4 ]
Johnson, Amy J. [4 ]
Kisseberth, William C. [1 ]
机构：
[1] Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA
[2] Acerta Pharma, San Carlos, CA USA
[3] Acerta Pharma, Oss, Netherlands
[4] Ohio State Univ, Div Hematol, Columbus, OH 43210 USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-1744
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1744
引用
收藏
页数：1
相关论文
共 50 条
  • [41] HCV and HGV in B-cell non-Hodgkin's lymphoma
    Ellenrieder, V
    Weidenbach, H
    Frickhofen, N
    Michel, D
    Prümmer, O
    Klatt, S
    Bernas, O
    Mertens, T
    Adler, G
    Beckh, K
    JOURNAL OF HEPATOLOGY, 1998, 28 (01) : 34 - 39
  • [42] Primary B-cell non-Hodgkin's lymphoma of the prostate
    Madhusudan, S
    John, LH
    Gillatt, D
    Price, CGA
    Pawade, J
    JOURNAL OF PATHOLOGY, 1999, 189 : 21A - 21A
  • [43] Antibody therapy of non-Hodgkin's B-cell lymphoma
    Chinn, P
    Braslawsky, G
    White, C
    Hanna, N
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2003, 52 (05) : 257 - 280
  • [44] Molecular Classification of Large B-Cell Non-Hodgkin Lymphoma
    Bojarczuk, Kamil
    Wienand, Kirsty
    Chapuy, Bjoern
    CANCER JOURNAL, 2020, 26 (04): : 357 - 361
  • [45] A comprehensive review of lenalidomide in B-cell non-Hodgkin lymphoma
    Arora, Mili
    Gowda, Sonia
    Tuscano, Joseph
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2016, 7 (04) : 209 - 221
  • [46] Loncastuximab Tesirine in Patients With B-Cell Non-Hodgkin Lymphoma
    Kahl, Brad S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (11) : 732 - 734
  • [47] Radioimmunotherapy for patients with relapsed B-cell non-Hodgkin lymphoma
    Thomas E. Witzig
    Cancer Chemotherapy and Pharmacology, 2001, 48 : S91 - S95
  • [48] Bruton's tyrosine kinase (Btk) is a useful marker for Hodgkin and B cell non-Hodgkin lymphoma
    Fernandez-Vega, Ivan
    Quiros, Luis M.
    Santos-Juanes, Jorge
    Pane-Foix, Maria
    Marafioti, Teresa
    VIRCHOWS ARCHIV, 2015, 466 (02) : 229 - 235
  • [49] Bruton’s tyrosine kinase (Btk) is a useful marker for Hodgkin and B cell non-Hodgkin lymphoma
    Iván Fernández-Vega
    Luis M. Quirós
    Jorge Santos-Juanes
    María Pane-Foix
    Teresa Marafioti
    Virchows Archiv, 2015, 466 : 229 - 235
  • [50] Expression of inhibitor of apoptosis proteins in B-cell non-Hodgkin and Hodgkin lymphomas
    Akyurek, Nalan
    Ren, Yongsheng
    Rassidakis, Georgios Z.
    Schlette, Ellen J.
    Medeiros, L. Jeffrey
    CANCER, 2006, 107 (08) : 1844 - 1851
12345